Aspect Biosystems: federal grants and contributions: 1 agreements; $79.0M value; 1 departments; 1 programs.
Assay record ASY-CA-0KE805K1WO · Cite as: Assay Systems, “Aspect Biosystems: federal grants and contributions”, https://assay-systems.com/register/ca/grants/r/aspect-biosystems/
This project will commercialize bioprinted tissue therapeutics, expand AI-enabled bioprinting and cell engineering capabilities, and establish a commercial-scale Current Good Manufacturing Practice biomanufacturing facility with end-to-end automation. The project’s work phase is scheduled to end on March 31, 2031.
All grants from Innovation, Science and Economic Development Canada
Contains information licensed under the Open Government Licence – Canada. Source: Government of Canada proactive disclosure of grants and contributions (open.canada.ca, dataset 432527ab-7aac-45b5-81d6-7597107a7013), 1,327,352 rows as published, collapsed to one agreement per agreement number (per reference number where none is given) at its latest amendment, which carries the full agreement value. Years are the agreement start year. Agreements with individuals are counted but not named.